For media inquiries: Julie Rathbun Rathbun Communications julie@rathbuncomm.com 206-769-9219
November 7, 2024
Mozart Therapeutics Announces Publication of MTX-101 Preclinical Data Demonstrating Modulation of Regulatory CD8 T Cell Network to Restore Immune Homeostasis
November 5, 2024
Mozart Therapeutics Announces Podium Presentation at Immunology of Diabetes Society Congress; Shows Potential for Lead Program, MTX-101, to Restore Insulin Production in Type 1 Diabetes
June 21, 2024
Mozart Therapeutics Announces Oral Presentation on MTX-101 at the 2024 American Diabetes Association’s 84th Scientific Sessions
More news Releases
